Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a headset at home lift depression? new study tests it

NCT ID NCT07217223

Recruiting now Symptom relief Sponsor: University of California, San Diego Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a safe, at-home brain stimulation device called tDCS can help people with depression that hasn't improved with standard treatments. Ten participants will use the device at home under remote supervision for two weeks. The goal is to see if the approach is feasible, safe, and tolerable, and to measure any changes in mood.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
transcranial direct current stimulation (tDCS) device
What this could lead to
If this works, it could point toward a convenient, home-based treatment option for people with hard-to-treat depression.
What could go wrong
This is a very small, early feasibility study with only 10 participants, so results may not apply widely. The treatment is experimental and may not improve depression.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER (MDD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Depressive Disorder, Treatment-Resistant major depressive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MAJOR DEPRESSIVE DISORDER (MDD) TREATMENT RESISTANT DEPRESSION (TRD)

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • UCSD Interventional Psychiatry

    RECRUITING

    San Diego, California, 92127, United States

    Contact Email: •••••@•••••

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.